Felix Baker

Felix James Baker is the founder of Baker Bros.
Advisors LP, founded in 2000, serving as Managing Member.
Current jobs include Chairman at Kymera Therapeutics, Inc. starting 2026; Non-Executive Chairman at Bicycle Therapeutics Plc starting 2025; Lead Independent Director at Kiniksa Pharmaceuticals Ltd. since 2015; Director at Kiniksa Pharmaceuticals Corp.; Independent Director at Kodiak Sciences, Inc. since 2015; Lead Independent Director at Kiniksa Pharmaceuticals International Plc since 2024; Director at N-Power Medicine, Inc.; Non-Executive Director at BeOne Medicines Ltd. starting 2026; Manager at Fbb2 LLC; Co-Managing Partner at Baker Bros.
Advisors GP LLC; Partner at FBB Associates; and Trustee at Memorial Sloan Kettering Cancer Center.
Former jobs include Chairman at Seagen, Inc. from 2022 to 2023; Chairman at Synageva BioPharma Corp.
from 2011 to 2015; Chairman at Talis Biomedical Corp.
from 2013 to 2023; Director at Neurogen Corp.
from 1999 to 2008; Independent Director at Alexion Pharmaceuticals, Inc. from 2015 to 2021; Director at Trimeris, Inc. from 2004 to 2011; Director at AnorMED, Inc.; Director at ConjuChem, Inc. from 1994 to 2006; Independent Director at Genomic Health, Inc. from 2012 to 2019; Director at ConjuChem Biotechnologies, Inc. from 2001 to 2009; Director at SlipChip Corp.; Independent Director at Ardea Biosciences, Inc. from 2010 to 2012; Director at Aquinox Pharmaceuticals, Inc.; Director at Presidio Pharmaceuticals, Inc.; Director at ConjuChem Biotechnologies, Inc.; Independent Director at IGM Biosciences, Inc. from 2021 to 2025; and Owner at VaxGen, Inc. Education includes undergraduate and doctorate degrees from Stanford University.